This is the authors' abstract. We don't add key points for this paper.
Interview with Dr. Jerry Avorn on a new estimate of the cost of bringing a drug to market. (12:09)Download An industry-supported center claims that it costs companies $2.6 billion to develop a new drug. But we need a broader-based and more transparent reckoning of research-and-development costs to inform discussions about fostering innovation and paying for medications.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jerry Avorn (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: